About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Society of Hematologic Oncology
Free SOHO Membership:
www.sohoonline.org
SOHO 2023
Leukemia
Lymphoma
Myeloma
MDS and MPN
Videos
SOHO 2022
Myeloma
Lymphoma
Leukemia
MDS and MPN
Benign Hematology
SOHO 2021
Myeloma
Cellular Therapy
Solid Tumors
Leukemia
MDS
Benign Hematology
MPN
Lymphoma
SOHO 2020
Basic Science
Lymphoma
Leukemia
Myeloma
MDS and MPN
Benign Hematology
SOHO Highlights: State of the Art and Next Questions
SOHO 2019
Hodgkin Lymphoma
Multiple Myeloma
Chronic Lymphocytic Leukemia
Meet The Professor Sessions
Chronic Myeloid Leukemia
Myeloproliferative Neoplasms
Breakfast With The Expert
Independent Satellite Symposium
Plenary Sessions
Evolving Practices in AML: A Case-based Guide to New and Emerging Treatment Options
Acute Lymphoblastic Leukemia
Myelodysplastic Syndromes
Acute Myeloid Leukemia
Indolent B-cell Lymphoma
Mantle Cell Lymphoma
Aggressive B-cell Lymphoma
T-cell Lymphoma
Cellular Therapy
Next Questions
SOHO 2018
Session I: Chronic Myeloid Leukemia
Session II: Myelodysplastic Syndromes
Session III: Myeloproliferative Neoplasms
Session IV: Acute Lymphoblastic Leukemia
Session V: Acute Myeloid Leukemia
Session VI: Multiple Myeloma
Session VIII: Non-Hodgkin Lymphoma
Session IX: Chronic Lymphocytic Leukemia
Session X: Research Topics
Plenary Sessions
Breakfast with the Expert
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
K
R/R PTCL State of the Art: Allo-SCT vs. Auto-SCT? Can Pralatrexate Change the Tumor Volume? Does Duvelisib+Romidepsin Increase ORR?
By
SOHO Highlights: State of the Art and Next Questions
FEATURING
Kerry Savage
By
SOHO Highlights: State of the Art and Next Questions
FEATURING
Kerry Savage
16 views
February 3, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
24:08
Indy Hematology Review
Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…
Feat.
A. Tefferi
Featured Video
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
SOHO Highlights: State of the Art and Next Questions
14:42
SOHO Highlights: State of the Art and Next Questions
SOHO Highlights on Non-Bulky cHL: Can We Treat Early Disease With Sh…
Feat.
D. Straus
09:24
SOHO Highlights: State of the Art and Next Questions
ECHELON-1 Data on Brentuximab Vedotin for Frontline Advanced cHL: Ex…
Feat.
D. Straus
10:47
SOHO Highlights: State of the Art and Next Questions
Surveying the Induction and Maintenance Therapy Landscape in Newly D…
Feat.
S. Lonial
20:52
SOHO Highlights: State of the Art and Next Questions
MM State of the Art: Approaches to Smoldering, MRD as a Prognostic M…
Feat.
S. Lonial
29:37
SOHO Highlights: State of the Art and Next Questions
CML State of the Art: Dasatinib/Imatinib Dose Optimization, STAMPi A…
Feat.
M. Deininger
34:50
SOHO Highlights: State of the Art and Next Questions
MPNs State of the Art: What Is the Response to Ruxolitinib vs. BAT? …
Feat.
S. Verstovsek
27:43
SOHO Highlights: State of the Art and Next Questions
MDS State of the Art: Imetelstat/Roxadustat for Anemia, Oral HMAs, A…
Feat.
G. Garcia-Manero
11:39
SOHO Highlights: State of the Art and Next Questions
Early Stage cHL Management: Bulky vs. Non-bulky Disease, Better Chem…
Feat.
D. Straus
14:25
SOHO Highlights: State of the Art and Next Questions
SOHO Highlights on Untreated MCL: How Does Deferred Therapy Work? Wh…
Feat.
J. Cohen
19:43
SOHO Highlights: State of the Art and Next Questions
SOHO Highlights on R/R MCL: The Role of BTKis, CAR-T, and Chemothera…
Feat.
J. Cohen
14:40
SOHO Highlights: State of the Art and Next Questions
Newly Diagnosed ALCL/PTCL State of the Art: How Can We Improve Outco…
Feat.
K. Savage
20:07
SOHO Highlights: State of the Art and Next Questions
R/R PTCL State of the Art: Allo-SCT vs. Auto-SCT? Can Pralatrexate C…
Feat.
K. Savage
13:36
SOHO Highlights: State of the Art and Next Questions
SOHO Updates on 1L FL: Does RT+/-(R)CVP Improve PFS in Limited Stage…
Feat.
R. Marcus
18:07
SOHO Highlights: State of the Art and Next Questions
SOHO Updates on 1L MZL: Can RT Help in Early Stage MALToma? Is R-Ben…
Feat.
R. Marcus
34:46
SOHO Highlights: State of the Art and Next Questions
DLBCL State of the Art: Does Gene Expression Help With the Disease? …
Feat.
S. Dave
24:38
SOHO Highlights: State of the Art and Next Questions
Dana-Farber CLL State of the Art: A Review of BTK Inhibitors Data in…
Feat.
J. Brown
24:52
SOHO Highlights: State of the Art and Next Questions
CAR-T State of the Art: What Therapies Will Be Available in the Next…
Feat.
S. Giralt
29:51
SOHO Highlights: State of the Art and Next Questions
AML State of the Art: Older Patients Management, MRD, Total Oral Com…
Feat.
A. Zeidan
29:28
SOHO Highlights: State of the Art and Next Questions
ALL State of the Art at MD Anderson: Hyper-CVAD Combinations, MiniHC…
Feat.
H. Kantarjian
